Page last updated: 2024-10-24
celecoxib and Cyst
celecoxib has been researched along with Cyst in 2 studies
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Autosomal dominant polycystic kidney disease (ADPKD) is a progressive chronic kidney disease." | 5.38 | Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. ( Fu, LL; Mei, CL; Wang, NS; Xu, T; Ye, CY; Yu, SQ, 2012) |
| "Autosomal dominant polycystic kidney disease (ADPKD) is a progressive chronic kidney disease." | 1.38 | Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway. ( Fu, LL; Mei, CL; Wang, NS; Xu, T; Ye, CY; Yu, SQ, 2012) |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Tellegen, AR | 1 |
| Rudnik-Jansen, I | 1 |
| Pouran, B | 1 |
| de Visser, HM | 1 |
| Weinans, HH | 1 |
| Thomas, RE | 1 |
| Kik, MJL | 1 |
| Grinwis, GCM | 1 |
| Thies, JC | 1 |
| Woike, N | 1 |
| Mihov, G | 1 |
| Emans, PJ | 1 |
| Meij, BP | 1 |
| Creemers, LB | 1 |
| Tryfonidou, MA | 1 |
| Xu, T | 1 |
| Wang, NS | 1 |
| Fu, LL | 1 |
| Ye, CY | 1 |
| Yu, SQ | 1 |
| Mei, CL | 1 |
Other Studies
2 other studies available for celecoxib and Cyst
| Article | Year |
|---|---|
Controlled release of celecoxib inhibits inflammation, bone cysts and osteophyte formation in a preclinical model of osteoarthritis.
Topics: Animals; Anterior Cruciate Ligament; Biocompatible Materials; Bone and Bones; Celecoxib; Cyclooxygen | 2018 |
Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Celecoxib; Cell Cycle Checkpoints; Cell P | 2012 |